Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/19863
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHEIDBUCHEL, Hein-
dc.contributor.authorVrijens, Bernard-
dc.date.accessioned2015-12-01T09:06:26Z-
dc.date.available2015-12-01T09:06:26Z-
dc.date.issued2015-
dc.identifier.citationEUROPACE, 17 (8), p. 1317-1318-
dc.identifier.issn1099-5129-
dc.identifier.urihttp://hdl.handle.net/1942/19863-
dc.language.isoen-
dc.publisherOXFORD UNIV PRESS-
dc.titleNon-vitamin K antagonist oral anticoagulants (NOAC): considerations on once- vs. twice-daily regimens and their potential impact on medication adherence-
dc.typeJournal Contribution-
dc.identifier.epage1318-
dc.identifier.issue8-
dc.identifier.spage1317-
dc.identifier.volume17-
local.format.pages3-
local.bibliographicCitation.jcatA1-
dc.description.notes[Heidbuchel, Hein] Hasselt Univ, B-3500 Hasselt, Belgium. [Heidbuchel, Hein] Jessa Ziekenhuis, Jessa Hosp, B-3500 Hasselt, Belgium. [Vrijens, Bernard] MWV Healthcare, B-4600 Vise, Belgium.-
local.publisher.placeOXFORD-
local.type.refereedRefereed-
local.type.specifiedLetter-
dc.identifier.doi10.1093/europace/euv124-
dc.identifier.isi000361829700026-
item.accessRightsClosed Access-
item.validationecoom 2016-
item.fulltextWith Fulltext-
item.fullcitationHEIDBUCHEL, Hein & Vrijens, Bernard (2015) Non-vitamin K antagonist oral anticoagulants (NOAC): considerations on once- vs. twice-daily regimens and their potential impact on medication adherence. In: EUROPACE, 17 (8), p. 1317-1318.-
item.contributorHEIDBUCHEL, Hein-
item.contributorVrijens, Bernard-
crisitem.journal.issn1099-5129-
crisitem.journal.eissn1532-2092-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
selection (38).pdf
  Restricted Access		77.41 kBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

18
checked on Jan 1, 2026

WEB OF SCIENCETM
Citations

17
checked on Jan 5, 2026

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.